Literature DB >> 2592266

Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men.

S R Plymate1, J S Tenover, W J Bremner.   

Abstract

The circadian pattern in levels of serum total testosterone (T) in men becomes blunted with normal aging. However, because T not bound to sex hormone-binding globulin (non-SHBG-T) is felt to be a better representative of biologically available T than is total T, the possibility of a 24-h variation in non-SHBG-T in young men and the possibility that aging is associated with a blunting of that rhythm were investigated. Hourly blood samples were drawn on 10 normal young men (mean age 27.3 years) and 10 normal elderly men (mean age 70.7 years) over a 24-h period and the serum was assayed for total T, sex hormone-binding globulin (SHBG), and total protein; non-SHBG-T was calculated. SHBG was determined by radioimmunoassay as well as by a steroid-binding assay. Young men had a significantly higher (p less than 0.05) mean 24-h level of non-SHBG-T (1.91 +/- 0.62 nm/l) than did the elderly men (0.86 +/- 0.01 nM/l). Also, each young man showed a significant circadian rhythm in non-SHBG-T, with a group mean daily variation of 1.42 +/- 0.38 nM/l. In contrast, only 60% of the elderly men demonstrated a significant circadian rhythm in non-SHBG-T, and the group mean rhythm was blunted (maximum excursion 0.38 +/- 0.07 nM/l) compared with that of the young men. SHBG and total protein levels demonstrated similar 24-h variations in the two age groups. It was concluded that non-SHBG-T serum levels, similar to serum total T levels, demonstrate a circadian pattern in young men and this circadian rhythmicity becomes blunted with normal aging.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592266     DOI: 10.1002/j.1939-4640.1989.tb00120.x

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  37 in total

1.  Does "clock" matter in prostate cancer?

Authors:  Yong Zhu; Tongzhang Zheng; Richard G Stevens; Yawei Zhang; Peter Boyle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

2.  Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels.

Authors:  M Y Roth; N Ilani; C Wang; S T Page; W J Bremner; R S Swerdloff; C Dart; R Sitruk-Ware; N Kumar; D Blithe; J K Amory
Journal:  Andrology       Date:  2013-09-30       Impact factor: 3.842

Review 3.  Role of circadian neuroendocrine rhythms in the control of behavior and physiology.

Authors:  Henryk F Urbanski
Journal:  Neuroendocrinology       Date:  2011-04-21       Impact factor: 4.914

4.  Morphological and morphometric study of early changes in the ageing golden hamster testis.

Authors:  R Horn; L M Pastor; E Moreno; A Calvo; M Canteras; J Pallares
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

5.  Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapy.

Authors:  Hideyasu Tsumura; Takefumi Satoh; Hiromichi Ishiyama; Shuhei Hirano; Ken-Ichi Tabata; Shinji Kurosaka; Kazumasa Matsumoto; Tetsuo Fujita; Masashi Kitano; Shiro Baba; Kazushige Hayakawa; Masatsugu Iwamura
Journal:  World J Radiol       Date:  2015-12-28

6.  Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.

Authors:  M Y Roth; S T Page; K Lin; B D Anawalt; A M Matsumoto; C N Snyder; B T Marck; W J Bremner; J K Amory
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

7.  Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection.

Authors:  Anne K Monroe; Adrian S Dobs; Xiaoqiang Xu; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Todd T Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

Review 8.  Cognitive effects of hormone therapy in men with prostate cancer: a review.

Authors:  Christian J Nelson; Jennifer S Lee; Maria C Gamboa; Andrew J Roth
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

9.  Serum LH correlates highly with intratesticular steroid levels in normal men.

Authors:  Mara Y Roth; K Lin; J K Amory; A M Matsumoto; B D Anawalt; C N Snyder; T F Kalhorn; W J Bremner; S T Page
Journal:  J Androl       Date:  2009-09-24

10.  Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.

Authors:  Yong Zhu; Richard G Stevens; Aaron E Hoffman; Liesel M Fitzgerald; Erika M Kwon; Elaine A Ostrander; Scott Davis; Tongzhang Zheng; Janet L Stanford
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.